Lv3
340 积分 2024-09-28 加入
CD160 dictates anti-PD-1 immunotherapy resistance by regulating CD8+ T cell exhaustion in colorectal cancer
11小时前
已完结
Chemotherapy modulates PD-L1 expression and its combination with immune checkpoint blockade requires precision
1个月前
已完结
Chemotherapy modulates PD-L1 expression and its combination with immune checkpoint blockade requires precision
1个月前
已完结
Anthracyclines potentiate anti-tumor immunity: A new opportunity for chemoimmunotherapy
2个月前
已完结
Blinatumomab in pediatric acute lymphoblastic leukemia: current and future use
2个月前
已完结
Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation
2个月前
已完结
Blinatumomab: First Global Approval
2个月前
已完结
Blinatumomab: A historical perspective
2个月前
已完结
Immunotherapy of lymphoma and leukemia with T-cell engaging BiTE antibody blinatumomab
2个月前
已完结
Single-Cell Analysis of Hematopoietic Stem Cells
2个月前
已完结
皖公网安备34019202002308
